Synopsis: This white paper shares findings from a new survey about how mergers and acquisitions (M&As) affect healthcare facilities and clinical data management practices. It includes insights from hospital leaders at Carle Health System and Corewell Health and offers strategies for navigating M&As while prioritizing clinical data.

Details:

Mergers and acquisitions (M&As) in healthcare are on the rise, and their impact on clinical data can be significant. According to a new Q-Centrix survey, 87% of hospital leaders who have experienced an M&A said the M&A changed how their facility managed its clinical data.  

Our latest white paper shares findings from Q-Centrix’s survey about how mergers and acquisitions (M&As) affect healthcare facilities and clinical data management practices. It also includes insights from hospital leaders who have gone through M&As and offers strategies for navigating M&As while prioritizing clinical data. 

By recognizing the pivotal role of clinical data management and addressing it proactively, healthcare leaders can usher in a smoother transition and set their health system up for success going forward. 

This article is for:

• Healthcare leaders who may be experiencing or planning for an M&A 
• Those interested in understanding how M&As impact clinical data management 
• Healthcare leaders looking for strategies to help ensure a smoother M&A transition